{"id":6172,"date":"2023-01-30T07:20:22","date_gmt":"2023-01-30T15:20:22","guid":{"rendered":"https:\/\/allocare.caredx.com\/?p=6172"},"modified":"2023-01-30T07:20:30","modified_gmt":"2023-01-30T15:20:30","slug":"fda-evusheld-no-longer-authorized-to-prevent-covid-19-in-us-until-further-notice","status":"publish","type":"post","link":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/indexphp\/post\/2023\/01\/30\/fda-evusheld-no-longer-authorized-to-prevent-covid-19-in-us-until-further-notice\/","title":{"rendered":"FDA: Evusheld no longer authorized to prevent COVID-19 in US \u2018until further notice\u2019"},"content":{"rendered":"<span class=\"simplefavorite-button has-count loading\" data-postid=\"6172\" data-siteid=\"1\" data-groupid=\"1\" data-favoritecount=\"0\" style=\"\">Loading<span class=\"sf-icon-spinner-wrapper\"><i class=\"sf-icon-spinner\"><\/i><\/span><\/span>\n<p>Evusheld is no longer authorized for use to help prevent COVID-19 in the United States \u201cuntil further notice,\u201d due to a lack of protection against dominant variants, according to new guidance issued by the FDA.<\/p>\n\n\n\n<p>In its updated guidance, the FDA limited the use of\u00a0<a rel=\"noreferrer noopener\" href=\"https:\/\/www.healio.com\/news\/rheumatology\/20220630\/fda-announces-new-evusheld-dosing-guidelines-shelflife-extension\" target=\"_blank\">Evusheld (tixagevimab plus cilgavimab, AstraZeneca)<\/a>\u00a0to when the combined national frequency of variants that are not susceptible to the treatment is 90% or less. <a href=\"https:\/\/www.healio.com\/news\/rheumatology\/20230126\/fda-evusheld-no-longer-authorized-to-prevent-covid19-in-us-until-further-notice?utm_source=selligent&amp;utm_medium=email&amp;utm_campaign=news&amp;M_BT=7635131937835\">Read more in Healio. <\/a><\/p>\n<span class=\"simplefavorite-button has-count loading\" data-postid=\"6172\" data-siteid=\"1\" data-groupid=\"1\" data-favoritecount=\"0\" style=\"\">Loading<span class=\"sf-icon-spinner-wrapper\"><i class=\"sf-icon-spinner\"><\/i><\/span><\/span>","protected":false},"excerpt":{"rendered":"<p>Loading Evusheld is no longer authorized for use to help prevent COVID-19 in the United States \u201cuntil further notice,\u201d due to a lack of protection against dominant variants, according to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/indexphp\/post\/2023\/01\/30\/fda-evusheld-no-longer-authorized-to-prevent-covid-19-in-us-until-further-notice\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;FDA: Evusheld no longer authorized to prevent COVID-19 in US \u2018until further notice\u2019&#8221;<\/span><\/a><\/p>\n","protected":false},"author":208,"featured_media":872,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_EventAllDay":false,"_EventTimezone":"","_EventStartDate":"","_EventEndDate":"","_EventStartDateUTC":"","_EventEndDateUTC":"","_EventShowMap":false,"_EventShowMapLink":false,"_EventURL":"","_EventCost":"","_EventCostDescription":"","_EventCurrencySymbol":"","_EventCurrencyCode":"","_EventCurrencyPosition":"","_EventDateTimeSeparator":"","_EventTimeRangeSeparator":"","_EventOrganizerID":[],"_EventVenueID":0,"_OrganizerEmail":"","_OrganizerPhone":"","_OrganizerWebsite":"","_VenueAddress":"","_VenueCity":"","_VenueCountry":"","_VenueProvince":"","_VenueZip":"","_VenuePhone":"","_VenueURL":"","_VenueStateProvince":"","_VenueLat":"","_VenueLng":"","_tribe_blocks_recurrence_rules":"","_tribe_blocks_recurrence_description":"","_tribe_blocks_recurrence_exclusions":"","_ecp_custom_2":"","footnotes":""},"categories":[45,42],"tags":[1135,1594,1595],"post_format":[],"Dislikes":"","Likes":"","simplefavorites_count":"","views":"1213","post_likes_plusCounter":"1","post_dislikes_plusCounter":"1","acf":[],"_links":{"self":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts\/6172"}],"collection":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/users\/208"}],"replies":[{"embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/comments?post=6172"}],"version-history":[{"count":1,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts\/6172\/revisions"}],"predecessor-version":[{"id":6173,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/posts\/6172\/revisions\/6173"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/media\/872"}],"wp:attachment":[{"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/media?parent=6172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/categories?post=6172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/tags?post=6172"},{"taxonomy":"post_format","embeddable":true,"href":"https:\/\/app-allocare-wordpress-linux-prod.azurewebsites.net\/index.php\/wp-json\/wp\/v2\/post_format?post=6172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}